Top Myelodysplastic Syndrome (MDS) Treatment Companies

  1. Takeda Pharmaceuticals

  2. Bristol-Myers Squibb

  3. Lupin

  4. Accord Healthcare

  5. Otsuka

*Disclaimer: Top companies sorted in no particular order

Myelodysplastic Syndrome (MDS) Treatment Market Major Players

Myelodysplastic Syndrome (MDS) Treatment - Competitive Concentration

Myelodysplastic Syndrome (MDS) Treatment Market Concentration

List of Myelodysplastic Syndrome (MDS) Treatment Companies

  • Bristol Myers Squibb (Celgene)

  • Novartis

  • Takeda Pharmaceuticals

  • Abbvie

  • Jazz Pharmaceuticals

  • Otsuka Pharma

  • Amgen

  • AstraZeneca

  • Geron Corp.

  • Merck & Co. (Acceleron)

  • Gilead Sciences

  • Fate Therapeutics

  • Onconova Therapeutics

  • StemLine Therapeutics

  • Keros Therapeutics

  • Rigel Pharmaceuticals

  • Faron Pharmaceuticals

  • Astellas Pharma

  • BeiGene Ltd.

  • Suzhou ImmuneOnco

  • additional firms as identified

Get more insights on Myelodysplastic Syndrome (MDS) Treatment industry from our comprehensive report